Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Timothy Albertson

Professor of Pharmacology and Toxicology

University of California, Davis

United States

Research Interests

Explore related searches

Professors in United States Professors in Epidemiology Epidemiology professors in United States

About

Timothy Albertson is an Associate Professor at the University of California, Davis, USA. His research areas focus on pharmacological treatments for chronic diseases, including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and acute respiratory distress syndrome. Additionally, he has conducted studies related to the California Poison Control System, addressing issues such as water bead exposures and amatoxin mushroom calls.

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (9)

Eliot Spindel

Professor

Oregon Health & Science University

UNITED STATES

View details

Sara Auld

Associate Professor

Emory University

UNITED STATES

View details

Sheetal Gandotra

Assistant Professor

The University of Alabama

UNITED STATES

View details

Michelle Lim

Assistant Clinical Professor

University of California, Davis

UNITED STATES

View details

Angela Haczku

Elected Director-At-Large

University of California, Davis

UNITED STATES

View details

Gabrielle Liu

Assistant Professor of Clinical Internal Medicine

UC Davis Health System

UNITED STATES

View details

Satyan Lakshminrusimha

Executive Associate Dean

UC Davis Children's Hospital

UNITED STATES

View details

Laura Esserman

University of California

UNITED STATES

View details

Benjamin Singer

Vice Chair for Research, Department of Medicine; Lawrence Hicks Professor of Pulmonary Medicine; Associate Professor of Medicine & Biochemistry and Molecular Genetics

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Timothy Albertson

Research Interests

Explore related searches

About

Articles (18)

Treatment with Allogeneic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multicenter Phase 2b Clinical Trial (STAT)

Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial (Communications Medicine, (2025), 5, 1, (444), 10.1038/s43856-025-01126-9)

Pediatric Intravenous Acetaminophen Overdoses: A Continuing Iatrogenic Problem

Transient Neonatal Cyanosis Exacerbated by Inhaled Nitric Oxide

A ten-year retrospective California Poison Control System experience with water bead exposures: a growing problem

The Effects of Cyproheptadine on Severe COVID-19 From the ISPY-COVID Adaptive Platform Trial

Oxidative stress, burnout, National Institutes of Health, work relative value units, and Medicaid: Need for an emergency transfusion

A Response to: Letter to the Editor Regarding “Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination”

Acute adverse effects of F(ab’)₂AV and FabAV use for rattlesnake Envenomations: A four-year poison center study

Biological sex modulates lung injury severity in adolescent mice exposed to short-term aerosolized vitamin E acetate

Cost-Effective Drug Testing: Analytical Methodology, Best Practices, and Clinical Utility

Real-life observation of wildfire smoke–impaired COVID-19 vaccine immunity

Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial

Unmasking the Hidden Risk of Systemic Toxicity from Topical Salicylates

Update on the pharmacological treatment of chronic obstructive pulmonary disease

Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)

Investigational pharmacological agents for the treatment of ARDS

A ten-year retrospective California Poison Control System experience with possible amatoxin mushroom calls

Collaborators (9)

Eliot Spindel

Sara Auld

Sheetal Gandotra

Michelle Lim

Angela Haczku

Gabrielle Liu

Satyan Lakshminrusimha

Laura Esserman

Benjamin Singer

Make your next move.